American Well Corporation (AMWL) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $5.51. It has a SharesGrow Score of 40/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is AMWL = $5 (-9.3% upside).
Valuation: AMWL trades at a trailing Price-to-Earnings (P/E) of -1 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.04.
Financials: revenue is $249M, -3.4%/yr average growth. Net income is $96M (loss), growing at -9%/yr. Net profit margin is -38.4% (negative). Gross margin is 53.3% (+11.2 pp trend).
Balance sheet: total debt is $5M against $236M equity (Debt-to-Equity (D/E) ratio 0.02, conservative). Current ratio is 3.37 (strong liquidity). Debt-to-assets is 1.4%. Total assets: $324M.
Analyst outlook: 5 / 15 analysts rate AMWL as buy (33%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 73/100 (Pass), Growth 15/100 (Fail), Past 0/100 (Fail), Health 100/100 (Pass), Moat 58/100 (Partial), Future 26/100 (Fail), Income 10/100 (Fail).
